Hendra Virus: An Update on Diagnosis, Vaccination, and Biosecurity Protocols for Horses.

The research paper presents an update on the diagnosis, vaccination, and biosecurity protocols for horses affected by the Hendra virus. This virus, which has pteropid bats as its natural carrier, emerged in the 90s as a pathogen causing significant fatalities in both horses and humans.

Understanding Hendra Virus

• Hendra virus, or HeV, emerged as a zoonotic pathogen in the 1990s. As a zoonotic pathogen, it can be transmitted from animals to humans. Despite showing a low occurrence rate, or morbidity, it presents a high fatality rate, or mortality, in both horses and humans that do contract it.
• Pteropid bats, often referred to as flying foxes, are identified as the natural carriers of HeV. They also are reservoirs for other significant zoonotic viruses like Nipah and Ebola viruses.

Commercially Available Vaccine

• Equivac HeV is the only commercially available vaccine for Hendra virus, intended specifically for horses. This vaccine is produced by Zoetis, a company based in Parkville, Victoria, Australia.
• There are currently no commercial vaccines available for humans against this virus.

Epidemiology, Clinical Features, and Pathology of HeV

• The paper also offers an updated review on various aspects related to HeV including its epidemiology, clinical features, and pathology.
• Epidemiology refers to the incidence, distribution, and control of the Hendra virus in a population, be it humans or horses.
• Clinical features touch on the symptoms and progression of the virus in an infected individual.
• Pathology refers to the effects HeV has on the bodies of both horses and humans, potentially damaging tissues and organs.

Diagnosis, Management, and Prevention of HeV

• The research paper underlines the importance of proper diagnosis, management, and prevention strategies for Hearth virus.
• Diagnosis would involve identifying signs of the virus, conducting laboratory tests, and confirming the presence of the Hendra virus.
• Management refers to the healthcare approach after diagnosis – treating the symptoms, monitoring the infected individual, and limiting the spread of the virus.
• Prevention includes strategies to avoid the spreading of the virus (biosecurity measures), which could involve quarantine measures, sanitation practices, or controlling the virus in its natural reservoir.